Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers

Colloids and Surfaces B: Biointerfaces

Volumn 87, Issue 2, 2011, Pages 243-254

  Choonara, Yahya E ^a   Pillay, Viness ^a   Ndesendo, Valence M K ^a   du Toit, Lisa C ^a   Kumar, Pradeep ^a   Khan, Riaz A ^b   Murphy, Caragh S ^a   Jarvis, Debbie Leigh ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Molecular mechanics; Nano emulsion characterization; Polymeric nanoparticles; Sustained release; Tuberculosis; Zero order kinetics

Indexed keywords

NANOEMULSION; POLYMERIC NANOPARTICLES; SUSTAINED RELEASE; TUBERCULOSIS; ZERO ORDER KINETICS;

ALGINATE; CALCIUM CHLORIDE; DRUG PRODUCTS; EMULSIFICATION; EMULSIONS; EVAPORATION; HYDRAZINE; MECHANICS; MOLECULAR MECHANICS; PHASE TRANSITIONS; POLYDISPERSITY; POLYMERS; SURFACE ACTIVE AGENTS; ZETA POTENTIAL;

NANOPARTICLES;

ALGINIC ACID; CALCIUM CHLORIDE; ISONIAZID; NANOPARTICLE; POLYGLACTIN; RIFAMPICIN; SORBITAN OLEATE; STABILIZING AGENT;

ACIDITY; AGITATION; ALKALINITY; ARTICLE; CHEMICAL PHENOMENA; CHEMICAL PROCEDURES; CHEMOMETRIC ANALYSIS; COALESCENCE; CONTROLLED STUDY; CROSS LINKING; DISPERSION; ELECTROSTATIC REPULSION; EMULSION SOLVENT EVAPORATION; EMULSION SOLVENT SURFACTANT EVAPORATION; HYDROGEN BOND; IN VITRO STUDY; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MECHANICS ENERGY RELATIONSHIP; MOLECULAR MODEL; MORPHOLOGY; NANOEMULSION; NANOPARTICLE AGGLOMERATION; PARTICLE SIZE; PHYSICAL PHENOMENA; POLARIZABILITY; POLYDISPERSITY INDEX; PRIORITY JOURNAL; REFRACTIVITY COEFFICIENT; REVERSE EMULSION CATIONIC GELIFICATION; REVERSE EMULSION SURFACTANT CATIONIC GELIFICATION; SOLVATION; STERIC REPULSION; SURFACE TENSION; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; VAN DER WAALS INTERACTION; ZETA POTENTIAL;

ALGINATES; CALCIUM CHLORIDE; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; EMULSIONS; GLUCURONIC ACID; HEXOSES; HEXURONIC ACIDS; HUMANS; HYDROGELS; ISONIAZID; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; MODELS, MOLECULAR; NANOPARTICLES; ORGANIC CHEMISTRY PROCESSES; PARTICLE SIZE; POLYGLYCOLIC ACID; RIFAMPIN; SPECTRUM ANALYSIS; THERMODYNAMICS; TUBERCULOSIS;

EID: 79960436468     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.05.025     Document Type: Article

References (58)

1. Freitas R.A. Nanomed.: Nanotechnol. Biol. Med. 2005, 1:2-9.
2. Couvreur P., Dubernet C., Puissieux F. Eur. J. Pharm. Biopharm. 1995, 41:2-13.
3. Reis C.P., Neufeld R., Ribeiro A., Veiga F. Nanomed.: Nanotechnol. Biol. Med. 2006, 2:8-12.
4. Panyam J., Labhasetwar V. Mol. Pharm. 2004, 1:77-84.
5. Rosler A., Vandermeulen G., Klok H. Adv. Drug Deliv. Rev. 2001, 53:95-108.
6. Jain R.A. Biomaterials 2000, 21:2475-2490.
7. Anderson J.M., Shive M.S. Adv. Drug Del. Rev. 1997, 28:5-24.
8. Kumari A., Yadav S.K., Yadav S.C. Colloids Surf. B Biointerfaces 2010, 75:1-18.
9. Tonnesen H., Karlsen J. Drug Dev. Ind. Pharm. 2002, 28:621-630.
10. Kumar M.N.V., Bakowsky U., Lehr C.M. Biomaterials 2004, 25:1771-1777.
11. Aslani P., Kennedy R.A. J. Control. Rel. 1996, 42:75-82.
12. Allemann E., Gurny R., Doelker F. Int. J. Pharm. 1992, 87:247-253.
13. Murakami H., Kawashima Y., Niwa Y., Hino T., Takeuchi H., Kobayashi M. Int. J. Pharm. 1997, 149:43-49.
14. Kim S., Marion M., Jeong B.H., Hoek E.M.V. J. Membr. Sci. 2006, 284:361-372.
15. Quintanar-Guerrero D., Ganem-Quintanar A., Allemann E., Fessi H., Doelker E. J. Microencapsulation 1998, 15:107-119.
16. Choi S.W., Kwon H.Y., Kim W.S., Kim J.H. Colloids Surf. A: Physicochem. Eng. Aspect. 2002, 201:283-289.
17. Lee K.Y., Mooney D.J. Chem. Rev. 2001, 101:1869-1879.
18. Choonara Y.E., Pillay V., Singh N., Khan R.A., Ndesendo V.M.K. Biomed. Mater. 2008, 3:1-15.
19. Hamidi M., Azadi A., Rafiei P. Adv. Drug. Deliv. Rev. 2008, 60:1638-1649.
20. Wiacek A.E., Chibowski E., Wilk K. Colloids Surf. B Biointerfaces 2002, 25:243-256.
21. Henry C.M. Chem. Eng. News 2004, 82:37-42.
22. Hughes G.A. Nanomed.: Nanotechnol. Biol. Med. 2005, 1:22-30.
23. World Health Organization: Geneva Treatment of TB: Guidelines for National Programmes 2003.
24. Panchagnula R., Agrawal S. Int. J. Pharm. 2004, 271:1-4.
25. Blomberg B., Spinaci S., Fourie B., Laing R. Bull. WHO 2001, 79:61-79.
26. Blomberg B., Fourie B. Drugs 2003, 63:535-553.
27. Coupe A.J., Davis S.S., Wilding I.R. Pharm. Res. 1991, 8:360-364.
28. Shishoo C.J., Shah S.A., Rathod I.S., Savale S.S., Vora M.J. Int. J. Pharm. 2001, 228:53-67.
29. Digenis G.A. Multipaticulate Oral Drug Delivery 1994, 333-355. Marcel Dekker Inc., New York. I. Ghebre-Sellassie (Ed.).
30. Singh S., Mariappan T.T., Sharda N., Chakraborti A.K. Pharm. Pharmacol. Commun. 2000, 6:405-410.
31. Singh S., Mariappan T.T., Sharda N., Singh B. Pharm. Pharmacol. Commun. 2000, 6:491-494.
32. Mohan B., Sharda N., Singh S. J. Pharm. Biomed. Anal. 2003, 31:607-612.
33. Mariappan T.T., Jindal K.C., Singh S. J. Pharm. Biomed. Anal. 2004, 36:905-908.
34. Kumar P., Pillay V., Choonara Y.E., Modi G., Naidoo D., du Toit L.C. Int. J. Mol. Sci. 2011, 12:694-724.
35. Desgouilles S., Vauthier C., Bazile D., Vacus J., Grossiord J.L., Veillard M., Couvreur P. Langmuir 2003, 19:9504-9510.
36. Galindo-Rodriguez S., Allemann E., Fessi H., Doelker E. Pharm. Res. 2004, 21:1428-1439.
37. Kim D.H., Martin D.C. Biomaterials 2006, 27:3031-3037.
38. Bao H., Li L., Zhang H. J. Colloid Interface Sci. 2008, 328:270-277.
39. Ni N., Tesconi M., Tabibi S.E., Gupta S., Yalkowsky S.H. Int. J. Pharm. 2001, 226:39-46.
40. Suslick K.S., Hyeon T., Fang F. Chem. Mater. 1996, 8:2172-2179.
41. Sunstrom J.E., Moser W.R., Marshik-Guerts B. Chem. Mater. 1996, 8:2061-2067.
42. Lamprecht A., Ubrich N., Perez H.M., Lehr C.M., Hoffman M., Maincent P. Int. J. Pharm. 1999, 184:97-105.
43. Budhian A., Siegel S.J., Winey K.I. Int. J. Pharm. 2007, 336:367-375.
44. Feng S., Huang G. J. Control. Rel. 2001, 71:53-69.
45. Fahr A., Muller K., Nahde T., Muller R., Brusselbach S. J. Liposome Res. 2002, 12:37-44.
46. Payet L., Ponton A., Leger L., Hervet H., Grossiord J.L., Agnely F. Macromolecules 2008, 41:9376-9381.
47. Anton N., Benoit J., Saulnier P. J. Control. Rel. 2008, 128:185-199.
48. Lensen D., Vriezema D.M., van Hest J.C.M. Macromol. Biosci. 2008, 8:991-1005.
49. Zhang K., Wu W., Meng H., Guo K., Chen J.F. Powder Technol. 2009, 190:393-400.
50. Lassalle V., María L., Ferreira M.L. Macromol. Biosci. 2009, 7:767-783.
51. Acharya S., Dilnawaz F., Sahoo S.K. Nanomedicine 2009, 4:519-530.
52. Peltonen L., Aitta J., Karjalainen M., Hirvonen J., Hirvonen J. AAPS PharmSci. 2004, 5:1-6.
53. Govender T., Stolnik S., Garnett M.C., Illum L., Davis S.S. J. Control. Rel. 1999, 57:171-185.
54. Tan A., Simovic S., Davey A.K., Rades T., Boyd B.J., Prestidge C.A. Mol. Pharm. 2010, 7:522-532.
55. Anderson C.D., Daniels E.S. Rapra Rev. Rep. 2003, 14(4):1-93.
56. Cheng J., Xu S., Wen L., Chen J. Langmuir 2005, 21:12047-12052.
57. Petkov J., Seóneóchal J., Guimberteau F., Leal-Calderon F. Langmuir 1998, 14:4011-4016.
58. Leonard M.S., Khaledi M.G. J. Sep. Sci. 2002, 25:1019-1026.